Saturday 17 October 2026
Export ACB’s income statement to Excel — free account
Aurora Cannabis Inc.
ACB Healthcare Drug Manufacturers Specialty & Generic
Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025. In the quarter to June 2026, revenue fell 31.2%, EPS grew 75.0%, free cash flow fell 293.6% and total debt fell 82.5%, each against the same quarter a year earlier.
3.99
0.11
−2.68%
Follow ACB
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 3 | 4 |
+8 more TTM periods Free account |
| (19.85%) | (21.82%) | (15.13%) | (10.17%) | ||
| (15.19%) | (16.82%) | (10.88%) | (7.47%) | ||
ROIC |
(5.58%) | (7.98%) | (8.26%) | (3.88%) | |
Return on Tangible Assets |
(23.74%) | (26.81%) | (15.94%) | (10.46%) | |
Average Days of Receivables |
51.59 | 50.75 | 43.27 | 47.12 | |
Free Cash Flow per Share |
(0.59) | (0.45) | (0.37) | (0.21) | |
Free Cash Flow |
(36.10) | (25.30) | (21.26) | (12.09) | |
Capital Expenditures |
(15.79) | (15.52) | (14.44) | (13.72) | |
| Other line items | |||||
Cash ROIC |
(7.21%) | (5.03%) | (3.63%) | (2.07%) | |
Accounts Receivable Turnover |
7.24 | 7.39 | 7.97 | 8.29 | |
Accounts Payable Turnover |
2.11 | 2.97 | 3.55 | 4.59 | |
Inventory Turnover |
0.70 | 0.89 | 1.01 | 0.93 | |
Average Days of Payables |
141.96 | 100.39 | 101.61 | 88.49 | |
Days of Inventory on Hand |
468.48 | 347.40 | 344.37 | 398.07 | |
Tax Rate |
0.06 | 0.04 | 0.09 | 0.16 | |
Research and Development Expense of Revenue |
1.97% | 1.25% | 1.02% | 0.94% | |
Selling, General and Administrative Expense of Revenue |
58.29% | 54.12% | 48.40% | 48.68% | |
Share Based Compensation of Revenue |
2.00% | 2.27% | 2.43% | 3.04% | |
Interest Coverage |
(70.51) | (25.80) | (7.73) | (3.84) | |
Operating CF/Net income |
0.25 | 0.11 | 0.11 | (0.04) | |
Depreciation/Fixed assets |
0.11 | 0.15 | 0.11 | 0.10 | |
Capex/Depreciation |
(1.38) | (1.19) | (0.70) | (0.69) | |
Revenue per Share |
3.40 | 4.09 | 4.71 | 4.65 | |
Operating CF per Share |
(0.33) | (0.17) | (0.12) | 0.03 | |
Capex per Share |
(0.26) | (0.27) | (0.25) | (0.24) | |
Capex to Sales |
0.08 | 0.07 | 0.05 | 0.05 |
Columns are period end dates